Bone Targeting Nanoparticles for the Treatment of Osteoporosis
International Journal of Nanomedicine · 2024-02 · Volume 19 · 1363-1383
DOI: 10.2147/ijn.s444347 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2024-02. Verfasst von Caining Wen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, People's Republic of China. Hauptthemen laut MEDLINE: Osteoporosis, Bone Resorption, Nanoparticles. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, People's Republic of China.
- Department of Chemistry, the Chinese University of Hong Kong, Shatin, Hong Kong SAR, People's Republic of China.
- Engineering Research Center of Intelligent Rehabilitation, College of Rehabilitation Medicine, Jining Medical University, Jining, Shandong, People's Republic of China.
ORCID-Profile: Yujie Liang
Zitieren
APA
Wen, C., Xu, X., Zhang, Y., Xia, J., Liang, Y., & Xu, L. (2024). Bone Targeting Nanoparticles for the Treatment of Osteoporosis. International Journal of Nanomedicine, Volume 19, 1363-1383. https://doi.org/10.2147/ijn.s444347
Vancouver
Wen C, Xu X, Zhang Y, Xia J, Liang Y, Xu L. Bone Targeting Nanoparticles for the Treatment of Osteoporosis. International Journal of Nanomedicine. 2024;Volume 19:1363-1383. doi:10.2147/ijn.s444347
BibTeX
@article{Wen2024,
author = {Wen, Caining and Xu, Xiao and Zhang, Yuanmin and Xia, Jiang and Liang, Yujie and Xu, Limei},
title = {Bone Targeting Nanoparticles for the Treatment of Osteoporosis},
journal = {International Journal of Nanomedicine},
year = {2024},
volume = {Volume 19},
pages = {1363--1383},
doi = {10.2147/ijn.s444347}
}
EUVIMED